Correlation Between Visa and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Visa and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Aerovate Therapeutics, you can compare the effects of market volatilities on Visa and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Aerovate Therapeutics.
Diversification Opportunities for Visa and Aerovate Therapeutics
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Visa and Aerovate is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Visa i.e., Visa and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Visa and Aerovate Therapeutics
Taking into account the 90-day investment horizon Visa is expected to generate 1.48 times less return on investment than Aerovate Therapeutics. But when comparing it to its historical volatility, Visa Class A is 2.29 times less risky than Aerovate Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Aerovate Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 253.00 in Aerovate Therapeutics on October 20, 2024 and sell it today you would earn a total of 5.00 from holding Aerovate Therapeutics or generate 1.98% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Visa Class A vs. Aerovate Therapeutics
Performance |
| Timeline |
| Visa Class A |
| Aerovate Therapeutics |
Visa and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Visa and Aerovate Therapeutics
The main advantage of trading using opposite Visa and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.| Visa vs. American Express | Visa vs. PayPal Holdings | Visa vs. Capital One Financial | Visa vs. Upstart Holdings |
| Aerovate Therapeutics vs. Adagene | Aerovate Therapeutics vs. Acrivon Therapeutics, Common | Aerovate Therapeutics vs. Rezolute | Aerovate Therapeutics vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |